Company Filing History:
1 out of 96 
1 out of 182 
Years Active: 2024
Title: Han-Shu Hu: Innovator in Neurotensin Receptor Research
Introduction
Han-Shu Hu is a prominent inventor based in Miaoli County, Taiwan. He has made significant contributions to the field of biotechnology, particularly in the development of humanized antibodies targeting neurotensin receptor 1 (NTSR1). His innovative work has implications for treating various diseases related to NTSR1 activity.
Latest Patents
Han-Shu Hu holds a patent for "Humanized anti-human neurotensin receptor 1 antibodies and their uses." This patent describes a humanized anti-neurotensin receptor 1 (NTSR1) antibody or an antigen-binding fragment thereof. It also outlines methods for treating, prophylactic treating, and preventing diseases and disorders caused by or related to NTSR1 activity and signaling. Additionally, the patent includes a method or kit for detecting NTSR1 in a sample.
Career Highlights
Throughout his career, Han-Shu Hu has worked with notable organizations, including the Development Center for Biotechnology and the National Health Research Institutes. His work in these institutions has allowed him to advance his research and contribute to the scientific community.
Collaborations
Han-Shu Hu has collaborated with esteemed colleagues such as Cheng-Chou Yu and Shu-Ping Yeh. These partnerships have fostered innovation and have been instrumental in the development of his research projects.
Conclusion
Han-Shu Hu's contributions to the field of biotechnology, particularly through his patent on NTSR1 antibodies, highlight his role as an innovator. His work continues to pave the way for advancements in medical treatments related to neurotensin receptor activity.